These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7330552)

  • 21. [Results of treatment with plasmapheresis in myasthenic crisis and severe polyneuropathy].
    Usnarska-Zubkiewicz L; Bilińska M; Gruszka E
    Pol Arch Med Wewn; 1991 Dec; 86(6):416-9. PubMed ID: 1819792
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma exchange alone as therapy for myasthenia gravis.
    Keesey J; Buffkin D; Kebo D; Ho W; Herrmann C
    Ann N Y Acad Sci; 1981; 377():729-43. PubMed ID: 6951497
    [No Abstract]   [Full Text] [Related]  

  • 23. A comparison between IVIG and plasma exchange as preparations before thymectomy in myasthenia gravis patients.
    Alipour-Faz A; Shojaei M; Peyvandi H; Ramzi D; Oroei M; Ghadiri F; Peyvandi M
    Acta Neurol Belg; 2017 Mar; 117(1):245-249. PubMed ID: 27530310
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasmapheresis in the critically ill patient.
    Berlot G; Tomasini A; Silvestri L; Gullo A
    Kidney Int Suppl; 1998 May; 66():S178-81. PubMed ID: 9573599
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuromuscular disease: acute treatment for myasthenia gravis.
    Gilhus NE
    Nat Rev Neurol; 2011 Mar; 7(3):132-4. PubMed ID: 21386868
    [No Abstract]   [Full Text] [Related]  

  • 26. IVIG Versus PLEX in the Treatment of Worsening Myasthenia Gravis: What is the Evidence?: A Critically Appraised Topic.
    Dhawan PS; Goodman BP; Harper CM; Bosch PE; Hoffman-Snyder CR; Wellik KE; Wingerchuk DM; Demaerschalk BM
    Neurologist; 2015 May; 19(5):145-8. PubMed ID: 25970838
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [In-vitro and in-vivo studies on the selective immunoadsorption treatment of neurological diseases].
    Heininger K
    Schriftenr Neurol; 1993; 33():1-91. PubMed ID: 8327864
    [No Abstract]   [Full Text] [Related]  

  • 28. [Treatment of myasthenia gravis by plasma exchange and immunosuppressors].
    Goulon M; Estournet B; Gajdos P; Bussel A; Goulon C
    Rev Med Interne; 1980; 1(2):213-6. PubMed ID: 7256012
    [No Abstract]   [Full Text] [Related]  

  • 29. Anti-MuSK antibody myasthenia gravis: clinical findings and response to treatment in two large cohorts.
    Guptill JT; Sanders DB; Evoli A
    Muscle Nerve; 2011 Jul; 44(1):36-40. PubMed ID: 21674519
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Evaluation of plasma exchange in management of myasthenia gravis (author's transl)].
    Arahata K; Sato T; Narabayashi H
    Rinsho Shinkeigaku; 1981 Jul; 21(7):597-606. PubMed ID: 7307400
    [No Abstract]   [Full Text] [Related]  

  • 31. Comparative efficacy of low dose, daily versus alternate day plasma exchange in severe myasthenia gravis: a randomised trial.
    Trikha I; Singh S; Goyal V; Shukla G; Bhasin R; Behari M
    J Neurol; 2007 Aug; 254(8):989-95. PubMed ID: 17694386
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic plasma exchange in patients with neurological diseases: multicenter retrospective analysis.
    Kaya E; Keklik M; Sencan M; Yilmaz M; Keskin A; Kiki I; Erkurt MA; Sivgin S; Korkmaz S; Okan V; Doğu MH; Unal A; Cetin M; Altuntaş F; Ilhan O
    Transfus Apher Sci; 2013 Jun; 48(3):349-52. PubMed ID: 23619327
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma exchange in myasthenia gravis and multiple sclerosis.
    Balint B; Jovicić A; Apostolski S; Magdić B; Taseski J
    Vojnosanit Pregl; 2000; 57(5):11-5. PubMed ID: 11213670
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extracorporeal antibody elimination in neuroimmunological diseases.
    Toepfer M; Schiffl H; Sitter T; Pongratz D; Müller-Felber W
    Ther Apher; 1999 Aug; 3(3):268-70. PubMed ID: 10427627
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of plasma exchange on carbamazepine levels in a patient with myasthenia gravis and epilepsy.
    Siddiqi ZA; Holt A; Ahmed SN
    Epilepsia; 2005 Nov; 46(11):1841-2. PubMed ID: 16302866
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trend of indications for therapeutic plasma exchange at an Iranian university hospital.
    Shahidi S; Memarzadeh M; Kamali M; Naini AE
    Transfus Apher Sci; 2011 Apr; 44(2):119-22. PubMed ID: 21334978
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical application and the technical procedure of plasmapheresis].
    Gurland HJ; Samtleben W
    Internist (Berl); 1983 Jan; 24(1):14-26. PubMed ID: 6341277
    [No Abstract]   [Full Text] [Related]  

  • 38. Therapeutic hemapheresis.
    Saeed SM; Raman BK
    Henry Ford Hosp Med J; 1983; 31(1):47-56. PubMed ID: 6345476
    [No Abstract]   [Full Text] [Related]  

  • 39. [Favorable results of plasmapheresis in severe myasthenia gravis].
    Blom RJ; Kuks JB; Westerterp-Maas A; Oosterhuis HJ
    Ned Tijdschr Geneeskd; 1997 Feb; 141(8):381-4. PubMed ID: 9157298
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence-based review of therapeutic plasma exchange in neurological disorders.
    Chhibber V; Weinstein R
    Semin Dial; 2012; 25(2):132-9. PubMed ID: 22277020
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.